https://www.selleckchem.com/pr....oducts/pifithrin-u.h
Secondary prevention of ischaemic heart disease (IHD) is an important aspect of healthcare. To improve the prognosis of and control risk factors for IHD patients, we created a unique referral system called the Shizuoka IHD patient registry. From 2009 to 2013, we enrolled 1240 patients; they participated in follow-up until 2018. The risk factor target values were as follows low-density-lipoprotein cholesterol, 100 mg/dl; glycated haemoglobin of diabetes patients, 7%; systolic blood pressure, 130 mmHg; and diastolic blood
پسند
تبصرہ
بانٹیں
